Brandinium

Trademark search for:

DEDOXA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2006-02-01 — Application filed
  • 2006-02-07 — Application filed
  • 2006-07-23 — Assigned to examiner
  • 2006-07-24 — Final disposition recorded
  • 2006-07-24 — Final disposition recorded
  • 2006-10-06 — Assigned to examiner
  • 2007-01-23 — Office action issued
  • 2007-01-23 — Correspondence received in law office
  • 2007-01-24 — Teas/email correspondence entered
  • 2007-01-25 — Suspension letter written
  • 2007-01-25 — Letter of suspension e-mailed
  • 2007-08-03 — Suspension inquiry written
  • 2007-08-03 — Inquiry to suspension e-mailed
  • 2007-08-03 — Notification of inquiry as to suspension e-mailed
  • 2008-01-28 — Teas response to suspension inquiry received
  • 2008-01-28 — Correspondence received in law office
  • 2008-02-28 — Suspension letter written
  • 2008-02-28 — Letter of suspension e-mailed
  • 2008-02-28 — Notification of letter of suspension e-mailed
  • 2008-02-28 — Teas/email correspondence entered
  • 2008-02-28 — Assigned to lie
  • 2008-09-02 — Suspension checked - to attorney for action
  • 2008-10-14 — Suspension inquiry written
  • 2008-10-14 — Inquiry to suspension e-mailed
  • 2008-10-14 — Notification of inquiry as to suspension e-mailed
  • 2009-04-13 — Teas response to suspension inquiry received
  • 2009-04-15 — Suspension letter written
  • 2009-04-15 — Letter of suspension e-mailed
  • 2009-04-15 — Notification of letter of suspension e-mailed
  • 2009-04-15 — Teas/email correspondence entered
  • 2009-04-15 — Correspondence received in law office
  • 2009-04-24 — Teas response to suspension inquiry received
  • 2009-04-24 — Teas/email correspondence entered
  • 2009-04-24 — Correspondence received in law office
  • 2009-04-27 — Approved for pub - principal register
  • 2009-04-28 — Data modification completed
  • 2009-04-28 — Law office publication review completed
  • 2009-05-13 — Notice of publication
  • 2009-06-02 — Published for opposition
  • 2009-07-15 — Teas post publication amendment received
  • 2009-07-29 — Assigned to petition staff
  • 2009-08-05 — Post publication amendment - entered
  • 2009-08-18 — Registered-principal register
  • 2010-05-19 — Attorney/dom.rep.revoked and/or appointed
  • 2010-05-19 — Teas revoke/app/change addr of atty/dom rep received
  • 2016-01-26 — Teas change of correspondence received
  • 2016-03-25 — Cancelled sec. 8 (6-yr)
  • 2016-03-25 — Final status recorded

Owner Information

SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal CH
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal CH
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal CH

Correspondent

Patrick J. Concannon Locke Lord LLP
PO BOX 1470
Church Street Station
NEW YORK, NY 10008-1470

Filing Details

Filing Date:
2006-02-01
Status Date:
2016-03-25
Category:
Pharmaceuticals
Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.